Cargando…
5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis
Coronavirus disease 2019 (COVID-19) is a newly emerged infectious disease caused by a novel coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The rapid global emergence of SARS-CoV-2 highlights the importance and urgency for potential drugs to control the pandemic. The f...
Autores principales: | Zhao, Jianyuan, Liu, Qian, Yi, Dongrong, Li, Quanjie, Guo, SaiSai, Ma, Ling, Zhang, Yongxin, Dong, Dongxin, Guo, Fei, Liu, Zhenlong, Wei, Tao, Li, Xiaoyu, Cen, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800165/ https://www.ncbi.nlm.nih.gov/pubmed/35101534 http://dx.doi.org/10.1016/j.antiviral.2022.105254 |
Ejemplares similares
-
A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase
por: Zhao, Jianyuan, et al.
Publicado: (2021) -
2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors
por: Zhao, Jianyuan, et al.
Publicado: (2021) -
Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CL(pro)
por: Ma, Ling, et al.
Publicado: (2022) -
Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL(pro)
por: Ma, Ling, et al.
Publicado: (2022) -
SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis
por: Guo, Saisai, et al.
Publicado: (2022)